The percentage of individuals >=18 years of age with concurrent use of prescription opioids and benzodiazepines during the measurement year.
A lower rate indicates better performance.
-
-
1.5 Measure Type1.7 Electronic Clinical Quality Measure (eCQM)1.8 Level Of Analysis1.20 Testing Data Sources
-
1.14 Numerator
The number of individuals from the denominator with concurrent use of opioids and benzodiazepines for >=30 cumulative days during the measurement year.
-
1.15 Denominator
The denominator includes individuals >=18 years of age with >=2 prescription claims for opioid medications on different dates of service and with >=15 cumulative days’ supply during the measurement year. Individuals with cancer, sickle cell disease, or in hospice are excluded.
-
Exclusions
Individuals with cancer, sickle cell disease, or in hospice at any point during the measurement year are excluded from the denominator.
-
1.13a Data dictionary not attachedNo
-
Most Recent Endorsement ActivityEndorsed Patient Safety Spring Cycle 2021Initial EndorsementLast Updated
-
StewardPharmacy Quality AllianceSteward Organization POC EmailSteward Organization URLSteward Organization Copyright
COPYRIGHT 2021 PQA, INC. ALL RIGHTS RESERVED
-
-
-
Risk AdjustmentRisk adjustment approachOffRisk adjustment approachOffConceptual model for risk adjustmentOffConceptual model for risk adjustmentOff
-
-
-
6.1.2 Current or Planned Use(s)6.1.3 Current Use(s)
-